These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 310362)

  • 21. Vibriolytic IgG immunocyte response of mice after primary and secondary immunization with cholera somatic antigens.
    Friedman H
    Immunology; 1975 Aug; 29(2):283-99. PubMed ID: 51000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A controlled field trial of the effectiveness of cholera and cholera El Tor vaccines in the Philippines.
    Azurin JC; Cruz A; Pesigan TP; Alvero M; Camena T; Suplido R; Ledesma L; Gomez CZ
    Bull World Health Organ; 1967; 37(5):703-27. PubMed ID: 5300874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative study of reactions and serological response to cholera vaccines in a controlled field trial conducted in the USSR.
    Burgasov PN; Sumarokov AA; Lelikov VL; Marcuk LM; Fedenev VG; Dzaparidze MN; Karaeva LT; Derteva II
    Bull World Health Organ; 1976; 54(2):163-70. PubMed ID: 798636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of a live oral cholera vaccine in human volunteers.
    Woodward WE; Gilman RH; Hornick RB; Libonati JP; Cash RA
    Dev Biol Stand; 1976; 33():108-12. PubMed ID: 782960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spectroscopic characterization of antibodies adsorbed to aluminium adjuvants: correlation with antibody vaccine immunogenicity.
    Capelle MA; Brügger P; Arvinte T
    Vaccine; 2005 Feb; 23(14):1686-94. PubMed ID: 15705473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunogenicity and protective capacity of inactivated "vibrio cholerae" whole cell vaccines.
    Cryz SJ; Fürer E; Germanier R
    Dev Biol Stand; 1983; 53():67-72. PubMed ID: 6873478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective activity of cholera vaccines against E1 Tor cholera vibrios.
    PITTMAN M; FEELEY JC
    Bull World Health Organ; 1963; 28(3):379-83. PubMed ID: 13943861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Texas Star-SR: attenuated "Vibrio cholerae" oral vaccine candidate.
    Levine MM; Black RE; Clements ML; Young CR; Lanata C; Sears S; Honda T; Finkelstein R
    Dev Biol Stand; 1983; 53():59-65. PubMed ID: 6873477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune responses following killed whole vibrio-B subunit oral cholera vaccine in human volunteers.
    Pitisuttithum P; Migasena S; Suntharasamai P; Supanaranond W; Desakorn V; Prayurahong B
    Southeast Asian J Trop Med Public Health; 1989 Jun; 20(2):201-5. PubMed ID: 2609209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Formulation in tablets of a cholera whole cells inactivated vaccine candidate.
    Talavera A; Año G; Pino Y; Castaño J; Uribarri E; Riverón L; Gil S; Fernández S; Cedré B; Valmaseda T; Pérez JL; Infante JF; García L; Sierra G
    Vaccine; 2006 Apr; 24(16):3381-7. PubMed ID: 16460846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The current status of cholera vaccine development and experience with cholera vaccine trials in volunteers.
    Levine MM; Kaper JB; Herrington D; Losonsky G; Tacket C; Tall B
    Southeast Asian J Trop Med Public Health; 1988 Sep; 19(3):401-15. PubMed ID: 3217822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Botulinum antitoxins and antibacterial IgM and IgG antibodies in sera of persons immunized with botulinum polytoxoid combined with cholera vaccine. I. Response to botulinum toxoid.
    Galazka A; Rymkiewicz D; Aleksandrowicz J
    Arch Immunol Ther Exp (Warsz); 1976; 24(5):631-9. PubMed ID: 793566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Studies on the efficacy of cholera vaccination in a population sample of Bari].
    Barbuti S; Iandolo E; Leogrande G; Rizzo G; Jatta E; Di Bari C
    Ann Sclavo; 1975; 17(3):489-99. PubMed ID: 1230049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variable gene family usage of protective and non-protective anti-Vibrio cholerae O1 LPS antibody heavy chains.
    Wade TK; Wade WF
    Microbiol Immunol; 2008 Dec; 52(12):611-20. PubMed ID: 19120975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cholera update and vaccination problems].
    Fournier JM; Villeneuve S
    Med Trop (Mars); 1998; 58(2 Suppl):32-5. PubMed ID: 9812307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody response in the intestinal secretions of volunteers immunized with various cholera vaccines.
    Ganguly R; Clem LW; Bencić Z; Sinha R; Sakazaki R; Waldman RH
    Bull World Health Organ; 1975; 52(3):323-30. PubMed ID: 779998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune responses following one and two doses of the reformulated, bivalent, killed, whole-cell, oral cholera vaccine among adults and children in Kolkata, India: a randomized, placebo-controlled trial.
    Kanungo S; Paisley A; Lopez AL; Bhattacharya M; Manna B; Kim DR; Han SH; Attridge S; Carbis R; Rao R; Holmgren J; Clemens JD; Sur D
    Vaccine; 2009 Nov; 27(49):6887-93. PubMed ID: 19761838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of immune responses to inactivated influenza vaccines prepared in embryonated chicken eggs and MDCK cells in a mouse model.
    Nerome K; Kumihashi H; Nerome R; Hiromoto Y; Yokota Y; Ueda R; Omoe K; Chiba M
    Dev Biol Stand; 1999; 98():53-63; discussion 73-4. PubMed ID: 10494959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antigenicity testing of inactivated oral enteric bacterial vaccines for human use.
    Joó I
    Dev Biol Stand; 1976; 33():75-9. PubMed ID: 782974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experimental studies on cholera immunization. 4. The antibody response to formalinized Vibrio cholerae and purified endotoxin with special reference to protective capacity.
    Svennerholm AM
    Int Arch Allergy Appl Immunol; 1975; 49(4):434-52. PubMed ID: 808500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.